NASDAQ:NKTX Nkarta (NKTX) Stock Price, News & Analysis $1.14 +0.02 (+1.34%) Closing price 04:00 PM EasternExtended Trading$1.12 -0.01 (-1.32%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Nkarta Stock (NASDAQ:NKTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nkarta alerts:Sign Up Key Stats Today's Range$1.11▼$1.2250-Day Range$1.12▼$2.9552-Week Range$1.11▼$3.72Volume1.60 million shsAverage Volume1.70 million shsMarket Capitalization$81.38 millionP/E RatioN/ADividend YieldN/APrice Target$11.20Consensus RatingModerate Buy Company Overview Nkarta, Inc. is a clinical-stage biotechnology company developing cell therapies based on natural killer (NK) cells, immune cells that can identify and attack abnormal cells. The company’s approach uses donor-derived NK cells that are engineered to recognize cancer targets and intended for use as off-the-shelf treatments. Nkarta’s research programs have included NKX019, an engineered NK-cell therapy targeting CD19, a protein found on certain B-cell cancers, and NKX101, designed to recognize stress signals on cancer cells. These are investigational therapies, and the company does not have approved commercial products. Founded in 2015, Nkarta is based in South San Francisco, California. Its development work has focused on potential treatments for blood cancers, including B-cell malignancies and acute myeloid leukemia.AI Generated. May Contain Errors. Read More Nkarta Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks68th Percentile Overall ScoreNKTX MarketRank™: 3.390867831105 of 5 starsNkarta scored higher than 68% of companies evaluated by MarketBeat, and ranked 281st out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingModerate Buy Consensus RatingNkarta has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 1 strong buy rating, 5 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialNkarta has a consensus price target of $11.20, representing about 886.8% upside from its current price of $1.14.Amount of Analyst CoverageNkarta has only been the subject of 3 research reports in the past 90 days.Read more about Nkarta's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Nkarta are expected to grow in the coming year, from ($1.67) to ($1.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nkarta is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nkarta is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNkarta has a P/B Ratio of 0.38. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.94% of the float of Nkarta has been sold short.Short Interest Ratio / Days to CoverNkarta has a short interest ratio ("days to cover") of 2.87, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nkarta has recently increased by 12.14%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNkarta does not currently pay a dividend.Dividend GrowthNkarta does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.67 News SentimentNkarta has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Nkarta this week, compared to 2 articles on an average week.Search Interest9 people have searched for NKTX on MarketBeat in the last 30 days. This is an increase of 29% compared to the previous 30 days.MarketBeat Follows3 people have added Nkarta to their MarketBeat watchlist in the last 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nkarta insiders have not sold or bought any company stock.Percentage Held by Insiders9.80% of the stock of Nkarta is held by insiders.Percentage Held by Institutions80.54% of the stock of Nkarta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Nkarta's insider trading history. Receive NKTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nkarta and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NKTX Stock News HeadlinesNkarta, Inc. (NKTX) - What Are Researchers Thinking About This Stock?November 17 at 2:15 AM | americanbankingnews.comWhat is HC Wainwright's Forecast for Nkarta FY2026 Earnings?November 12, 2026 | americanbankingnews.comURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.November 20 at 1:00 AM | Paradigm Press (Ad)Nkarta Presents Initial Safety Data for NKX019 in 40 Patients Across Five Autoimmune Diseases at ACR Convergence 2026November 11, 2026 | globenewswire.comNkarta (NASDAQ:NKTX) Earns "Buy" Rating from Needham & Company LLCNovember 11, 2026 | americanbankingnews.comNkarta, Inc. (NKTX) Discusses Initial NKX019 Clinical Data in Myositis and Systemic Sclerosis TranscriptNovember 9, 2026 | seekingalpha.comNkarta Announces Initial Clinical Data for NKX019 in Myositis and Systemic Sclerosis at ACR ConvergenceNovember 9, 2026 | finance.yahoo.comNkarta reports initial NKX019 clinical responses in myositis and systemic sclerosis trialsNovember 9, 2026 | msn.comSee More Headlines NKTX Stock Analysis - Frequently Asked Questions How have NKTX shares performed this year? Nkarta's stock was trading at $1.85 on January 1st, 2026. Since then, NKTX stock has decreased by 38.6% and is now trading at $1.1350. How were Nkarta's earnings last quarter? Nkarta, Inc. (NASDAQ:NKTX) issued its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.40) by $0.05. When did Nkarta IPO? Nkarta (NKTX) raised $231 million in an initial public offering on Friday, July 10th 2020. The company issued 14,000,000 shares at a price of $16.00-$17.00 per share. Cowen, Evercore ISI, Stifel and Mizuho Securities served as the underwriters for the IPO. Who are Nkarta's major shareholders? Top institutional shareholders of Nkarta include State Street Corp (1.84%), Marshall Wace LLP (0.85%), Goldman Sachs Group Inc. (0.48%) and Empowered Funds LLC (0.15%). Insiders that own company stock include Paul J Hastings, Nadir Mahmood, James Trager and Alicia J Hager. View institutional ownership trends. How do I buy shares of Nkarta? Shares of NKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nkarta own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nkarta investors own include Micron Technology (MU), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Editas Medicine (EDIT), Gossamer Bio (GOSS) and Heron Therapeutics (HRTX). Company Calendar Last Earnings11/10/2026Today11/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 8 days, NKTX's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:NKTX CIK1787400 Webwww.nkartatx.com Phone925-407-1049FaxN/AEmployees103Year Founded2015Price Target and Rating Average Price Target for Nkarta$11.20 High Price Target$14.00 Low Price Target$9.00 Potential Upside/Downside+886.8%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($1.73) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$104.08 million Net MarginsN/A Pretax MarginN/A Return on Equity-48.58% Return on Assets-36.26% Debt Debt-to-Equity RatioN/A Current Ratio5.79 Quick Ratio5.79 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.01 per share Price / Book0.38Miscellaneous Outstanding Shares71,700,000Free Float64,677,000Market Cap$81.38 million OptionableOptionable Beta1.24 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:NKTX) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored6 Men Secretly Changed America’s Money. Now It’s Happening AgainIn 1910, six powerful men secretly met to lay the groundwork for the Federal Reserve, reshaping America's fina...Banyan Hill Publishing | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nkarta, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nkarta With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.